Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.

BMC Cancer · 2012 · PMC3472165 · PMID 22759347

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

In the WHI trial, postmenopausal women who randomly assigned to combination of estrogen plus progestin therapy group were at reduced risk for CRC compared to those assigned to placebo group, the reduction (37%) was nominally significant [ 12 ].

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.